Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 7
2020 7
2021 13
2022 11
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Lung Inflammation and Injury on Pulmonary Tissue Penetration of Meropenem and Vancomycin in a Model of Unilateral Lung Injury.
Geilen J, Kainz M, Zapletal B, Schweiger T, Jäger W, Maier-Salamon A, Zeitlinger M, Stamm T, Ritschl V, Geleff S, Schultz MJ, Tschernko E. Geilen J, et al. Among authors: ritschl v. Int J Antimicrob Agents. 2024 Apr 20:107180. doi: 10.1016/j.ijantimicag.2024.107180. Online ahead of print. Int J Antimicrob Agents. 2024. PMID: 38649034 Free article.
"If I have Sjögren's syndrome, I want to know it as early as possible": The perspective of first-degree relatives of patients with Sjögren's syndrome from an international survey.
Alunno A, Carubbi F, Ritschl V, Cornec D, Zenz S, Vieira A, Antonopoulou K, Chatzis L, Romão VC, Tzioufas A, Bandeira M, Stradner MH. Alunno A, et al. Among authors: ritschl v. Joint Bone Spine. 2024 Jan 28;91(4):105695. doi: 10.1016/j.jbspin.2024.105695. Online ahead of print. Joint Bone Spine. 2024. PMID: 38290661 No abstract available.
Antimicrobial Drug Penetration Is Enhanced by Lung Tissue Inflammation and Injury.
Geilen J, Kainz M, Zapletal B, Naka A, Tichy J, Jäger W, Böhmdorfer M, Zeitlinger M, Schultz MJ, Stamm T, Ritschl V, Geleff S, Tschernko E. Geilen J, et al. Among authors: ritschl v. Am J Respir Crit Care Med. 2024 Apr 1;209(7):829-839. doi: 10.1164/rccm.202306-0974OC. Am J Respir Crit Care Med. 2024. PMID: 38099833
Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Farisogullari B, Santos EJF, Dures E, Geenen R, Machado PM; EULAR taskforce on recommendations for the management of fatigue in people with inflammatory rheumatic diseases; EULAR taskforce on Recommendations for the management of fatigue in people withinflammatory rheumatic diseases. Farisogullari B, et al. RMD Open. 2023 Dec 6;9(4):e003349. doi: 10.1136/rmdopen-2023-003349. RMD Open. 2023. PMID: 38056919 Free PMC article.
2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Dures E, Farisoğulları B, Santos EJF, Molto A, Feldthusen C, Harris C, Elling-Audersch C, Connolly D, Elefante E, Estévez-López F, Bini I, Primdahl J, Hoeper K, Urban M, van de Laar MAFJ, Redondo M, Böhm P, Amarnani R, Hayward R, Geenen R, Rednic S, Pettersson S, Thomsen T, Uhlig T, Ritschl V, Machado PM. Dures E, et al. Among authors: ritschl v. Ann Rheum Dis. 2023 Nov 22:ard-2023-224514. doi: 10.1136/ard-2023-224514. Online ahead of print. Ann Rheum Dis. 2023. PMID: 38050029
Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Santos EJF, Farisogullari B, Dures E, Geenen R, Machado PM; EULAR taskforce on recommendations for the management of fatigue in people with inflammatory rheumatic diseases. Santos EJF, et al. RMD Open. 2023 Aug;9(3):e003350. doi: 10.1136/rmdopen-2023-003350. RMD Open. 2023. PMID: 37604639 Free PMC article.
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis.
Parodis I, Girard-Guyonvarc'h C, Arnaud L, Distler O, Domján A, Van den Ende CHM, Fligelstone K, Kocher A, Larosa M, Lau M, Mitropoulos A, Ndosi M, Poole JL, Redmond A, Ritschl V, Alexanderson H, Sjöberg Y, von Perner G, Uhlig T, Varju C, Vriezekolk JE, Welin E, Westhovens R, Stamm TA, Boström C. Parodis I, et al. Among authors: ritschl v. Ann Rheum Dis. 2023 Aug 23:ard-2023-224416. doi: 10.1136/ard-2023-224416. Online ahead of print. Ann Rheum Dis. 2023. PMID: 37433575
51 results